WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2024)
Top pharmaceutical stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
NBIX
NEUROCRINE BIOSCIENCES INC
$14.84BN/A0.00%N/AN/AN/AN/A
AMPH
AMPHASTAR PHARMACEUTICALS INC
$1.89BN/A0.00%N/AN/AN/AN/A
COLL
COLLEGIUM PHARMACEUTICAL INC
$1.04BN/A0.00%N/AN/AN/AN/A
PCRX
PACIRA BIOSCIENCES INC
$1.01BN/A0.00%N/AN/AN/AN/A
ANIP
ANI PHARMACEUTICALS INC
$1.33BN/A0.00%N/AN/AN/AN/A
SIGA
SIGA TECHNOLOGIES INC
$620.19M6.88%95.50%$0.6000$0.6089%0
LNTH
LANTHEUS HOLDINGS INC
$8.55BN/A0.00%N/AN/AN/AN/A
RDY
DR REDDYS LABORATORIES LTD
$13.28B0.61%24.30%$0.4877$0.4911%02024-07-15
ZTS
ZOETIS INC
$81.70B0.90%31.10%$0.4320$1.6118%02024-07-182024-09-04
SCYX
SCYNEXIS INC
$83.12MN/A0.00%N/AN/AN/AN/A
KMDA
KAMADA LTD
$356.95MN/A0.00%N/AN/AN/AN/A
HCM
HUTCHMED (CHINA) LTD
$3.38BN/A0.00%N/AN/AN/AN/A
ITCI
INTRA-CELLULAR THERAPIES INC
$8.25BN/A0.00%N/AN/AN/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.41BN/A0.00%N/AN/AN/AN/A
ALKS
ALKERMES PLC
$3.99B4.54%40.80%$1.0700$1.0777%0
CRON
CRONOS GROUP INC
$920.65MN/A0.00%N/AN/AN/AN/A
PAHC
PHIBRO ANIMAL HEALTH CORP
$708.00M2.75%145.50%$0.1200$0.4854%0
TLRY
TILRAY BRANDS INC
$1.46BN/A0.00%N/AN/AN/AN/A
EOLS
EVOLUS INC
$736.93MN/A0.00%N/AN/AN/AN/A
HLN
HALEON PLC
$41.09B0.52%15.90%$0.0460$0.058%0
ETON
ETON PHARMACEUTICALS INC
$87.60MN/A0.00%N/AN/AN/AN/A
SBFM
SUNSHINE BIOPHARMA INC
$6.27MN/A0.00%N/AN/AN/AN/A
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$3.51BN/A0.00%$0.4750N/AN/A0
ZOM
ZOMEDICA CORP
$148.95MN/A0.00%N/AN/AN/AN/A
TLPH
TALPHERA INC
$15.80MN/A0.00%N/AN/AN/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$12.03MN/A0.00%N/AN/AN/AN/A
OPTN
OPTINOSE INC
$143.56MN/A0.00%N/AN/AN/AN/A
PETQ
PETIQ INC
$656.33MN/A0.00%N/AN/AN/AN/A
TXMD
THERAPEUTICSMD INC
$21.34MN/A0.00%N/AN/AN/AN/A
PROC
PROCAPS GROUP SA
$289.96MN/A0.00%N/AN/AN/AN/A
ORGO
ORGANOGENESIS HOLDINGS INC
$385.79MN/A0.00%N/AN/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$78.18MN/A0.00%N/AN/AN/AN/A
TKNO
ALPHA TEKNOVA INC
$52.25MN/A0.00%N/AN/AN/AN/A
ESPR
ESPERION THERAPEUTICS INC
$475.55MN/A0.00%N/AN/AN/AN/A
YCBD
CBDMD INC
$2.25MN/A0.00%N/AN/AN/AN/A
EVOK
EVOKE PHARMA INC
$4.99MN/A0.00%N/AN/AN/AN/A
HROW
HARROW INC
$835.37MN/A0.00%N/AN/AN/AN/A
PRGO
PERRIGO CO PLC
$3.75B2.99%-1,825.00%$0.2760$0.8258%0
AVDL
AVADEL PHARMACEUTICALS PLC
$1.60BN/A0.00%N/AN/AN/AN/A
ACB
AURORA CANNABIS INC
$327.82MN/A0.00%N/AN/AN/AN/A
ASRT
ASSERTIO HOLDINGS INC
$157.91MN/A0.00%N/AN/AN/AN/A
ALIM
ALIMERA SCIENCES INC
$293.38MN/A0.00%N/AN/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$42.18BN/A0.00%$0.4064N/AN/A1
RMTI
ROCKWELL MEDICAL INC
$64.57MN/A0.00%N/AN/AN/AN/A
INCR
INTERCURE LTD
$113.02MN/A0.00%N/AN/AN/AN/A
ALVO
ALVOTECH
$3.24BN/A0.00%N/AN/AN/AN/A
AQST
AQUESTIVE THERAPEUTICS INC
$243.07MN/A0.00%N/AN/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$113.27MN/A0.00%N/AN/AN/AN/A
HUGE
FSD PHARMA INC
$5.78MN/A0.00%N/AN/AN/AN/A
SNOA
SONOMA PHARMACEUTICALS INC
$6.97MN/A0.00%N/AN/AN/AN/A
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$39.54MN/A-22.70%$0.2500N/AN/A0
FLGC
FLORA GROWTH CORP
$13.84MN/A0.00%N/AN/AN/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$12.70MN/A0.00%N/AN/AN/AN/A
DRRX
DURECT CORP
$42.83MN/A0.00%N/AN/AN/AN/A
RDHL
REDHILL BIOPHARMA LTD
$14.88MN/A0.00%N/AN/AN/AN/A
AYTU
AYTU BIOPHARMA INC
$15.54MN/A0.00%N/AN/AN/AN/A
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.57BN/A0.00%N/AN/AN/AN/A
SXTC
CHINA SXT PHARMACEUTICALS INC
$931.65kN/A0.00%N/AN/AN/AN/A
PTPI
PETROS PHARMACEUTICALS INC
$3.09MN/A0.00%N/AN/AN/AN/A
BFRI
BIOFRONTERA INC
$5.37MN/A0.00%N/AN/AN/AN/A
CTLT
CATALENT INC
$10.42BN/A0.00%N/AN/AN/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$558.08MN/A0.00%N/AN/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$36.06MN/A0.00%N/AN/AN/AN/A
INDV
INDIVIOR PLC
$1.48BN/A0.00%N/AN/AN/AN/A
IMCC
IM CANNABIS CORP
$5.51MN/AN/AN/AN/AN/AN/A
KALA
KALA BIO INC
$21.07MN/A0.00%N/AN/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$136.53MN/A0.00%N/AN/AN/AN/A
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$45.55MN/A0.00%N/AN/AN/AN/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$21.14MN/A0.00%N/AN/AN/AN/A
LFCR
LIFECORE BIOMEDICAL INC
$153.65MN/A0.00%N/AN/AN/AN/A
OGI
ORGANIGRAM HOLDINGS INC
$160.12MN/AN/AN/AN/AN/AN/A
CGC
CANOPY GROWTH CORP
$495.28MN/A0.00%N/AN/AN/AN/A
IXHL
INCANNEX HEALTHCARE INC
$43.59MN/AN/AN/AN/AN/AN/A
PRFX
PAINREFORM LTD
$902.92kN/A0.00%N/AN/AN/AN/A
EVO
EVOTEC SE
$1.75BN/AN/AN/AN/AN/AN/A
VTRS
VIATRIS INC
$13.38B2.14%-1,200.00%$0.1200$0.2445%0
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$19.57BN/A0.00%$0.0720N/AN/A3
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.03BN/A0.00%N/AN/AN/AN/A
BHC
BAUSCH HEALTH COMPANIES INC
$2.72BN/A0.00%N/AN/AN/AN/A
AKAN
AKANDA CORP
$497.41kN/A0.00%N/AN/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$6.82BN/A0.00%N/AN/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$4.24MN/A0.00%N/AN/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$7.12MN/A0.00%N/AN/AN/AN/A
AMRX
AMNEAL PHARMACEUTICALS INC
$2.22BN/A0.00%N/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$50.20MN/A0.00%N/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Jul 2024?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the top pharmaceutical stock with a Zen Score of 69, which is 43 points higher than the pharmaceutical industry average of 26. It passed 23 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock return 51.63% over the past year, overperforming other pharmaceutical stocks by 52 percentage points.

Neurocrine Biosciences has an average 1 year price target of $165.50, an upside of 12.26% from Neurocrine Biosciences's current stock price of $147.43.

Neurocrine Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Neurocrine Biosciences, 56.25% have issued a Strong Buy rating, 25% have issued a Buy, 18.75% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amphastar Pharmaceuticals (NASDAQ:AMPH)


Amphastar Pharmaceuticals (NASDAQ:AMPH) is the second best pharmaceutical stock with a Zen Score of 66, which is 40 points higher than the pharmaceutical industry average of 26. It passed 22 out of 33 due diligence checks and has strong fundamentals. Amphastar Pharmaceuticals has seen its stock lose -29.5% over the past year, underperforming other pharmaceutical stocks by -29 percentage points.

Amphastar Pharmaceuticals has an average 1 year price target of $65.50, an upside of 69.25% from Amphastar Pharmaceuticals's current stock price of $38.70.

Amphastar Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amphastar Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the third best pharmaceutical stock with a Zen Score of 59, which is 33 points higher than the pharmaceutical industry average of 26. It passed 19 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 47.4% over the past year, overperforming other pharmaceutical stocks by 48 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $40.75, an upside of 28.23% from Collegium Pharmaceutical's current stock price of $31.78.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Collegium Pharmaceutical, 50% have issued a Strong Buy rating, 25% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 6.88%, which is 4 percentage points higher than the pharmaceutical industry average of 2.67%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

2. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 4.54%, which is 2 percentage points higher than the pharmaceutical industry average of 2.67%.

Alkermes's dividend payout ratio of 40.8% indicates that its high dividend yield is sustainable for the long-term.

3. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 2.99%, which is the same as the pharmaceutical industry average of 2.67%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -1,825% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.36% in the last day, and up 7.32% over the last week. Qilian International Holding Group was the among the top gainers in the drug manufacturers - specialty & generic industry, gaining 29.51% yesterday.

Qilian International shares are trading higher after the company announced it regained Nasdaq compliance.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 86, which is 69 points higher than the pharmaceutical industry average of 17. It passed 6 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 47.4% in the past year. It has overperformed other stocks in the pharmaceutical industry by 48 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 71, which is 54 points higher than the pharmaceutical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -40.47% in the past year. It has underperformed other stocks in the pharmaceutical industry by -40 percentage points.

3. Amphastar Pharmaceuticals (NASDAQ:AMPH)


Amphastar Pharmaceuticals (NASDAQ:AMPH) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Amphastar Pharmaceuticals has a valuation score of 71, which is 54 points higher than the pharmaceutical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Amphastar Pharmaceuticals's stock has dropped -29.5% in the past year. It has underperformed other stocks in the pharmaceutical industry by -29 percentage points.

Are pharmaceutical stocks a good buy now?

62.75% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 28.05% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -1.24x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.